phenylhydrazine has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrasa, MI; Elmes, RR; Gao, X; Lee, HY; Li, H; Lodish, HF; Peters, LL | 1 |
| Flewelen, TC; Frei, AC; Hanson, MS; Hillery, CA; Hogg, N; Holzhauer, SL; Jones, DW; Pritchard, KA; Retherford, D; Wandersee, NJ; Xu, H | 1 |
2 other study(ies) available for phenylhydrazine and Chronic Disease
| Article | Year |
|---|---|
PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal.
Topics: Acute Disease; Anemia; Anemia, Hemolytic; Animals; Butyrates; Cell Culture Techniques; Cells, Cultured; Chromatin; Chronic Disease; Disease Models, Animal; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; Fenofibrate; Glucocorticoids; Humans; Liver; Mice; Phenylhydrazines; Phenylurea Compounds; PPAR alpha; Receptors, Glucocorticoid; Signal Transduction | 2015 |
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
Topics: Acute Disease; Anemia, Hemolytic; Anemia, Sickle Cell; Animals; Apolipoproteins E; Chronic Disease; Disease Models, Animal; Endocytosis; Half-Life; Hemoglobins; Hemolysis; Humans; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Peptide Fragments; Peptides; Phenylhydrazines; Protein Binding; Protein Transport; Spherocytosis, Hereditary; Vasodilation; Vasodilator Agents | 2013 |